Clinical Trial Update: Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial update on QL1012 evaluating efficacy and safety in women for assisted reproductive treatment (infertility).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• QL1012

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Infertility | Phase 3 | Status: COMPLETED